SRPT — Sarepta Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on SRPT
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-13 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-06-15 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-08 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-03-30 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-03-10 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-28 | SEVERINO MICHAEL Chief Executive Officer | Grant or award | 756.1K | — | — |
| 2026-06-04 | Barry Richard Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | Nicaise Claude Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | Boor Kathryn Jean Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | Connelly Deirdre P Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | Mayo Stephen Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | BEHRENS M KATHLEEN Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | Wigzell Hans Lennart Rudolf Director | Grant or award | 16.9K | — | — |
| 2026-06-04 | Chambers Michael Andrew Director | Grant or award | 16.9K | — | — |
| 2026-03-12 | Mayo Stephen Director | Open-market sale | 7.2K | 17.02 | 123.2K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 321.1M | 14.8M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 144.5M | 6.6M |
| STATE STREET CORP | 143.9M | 6.6M |
| AQR CAPITAL MANAGEMENT LLC | 138.6M | 6.4M |
| TWO SIGMA INVESTMENTS, LP | 99.9M | 4.6M |
| VANGUARD CAPITAL MANAGEMENT LLC | 99.6M | 4.6M |
| FIRST TRUST ADVISORS LP | 90.0M | 4.1M |
| RA CAPITAL MANAGEMENT, L.P. | 84.9M | 3.9M |
| Erste Asset Management GmbH | 61.3M | 3.0M |
| MORGAN STANLEY | 56.5M | 2.6M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 13F-HR | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| SCHEDULE 13G | 2026-08-07 | — | on EDGAR ↗ |
| 8-K | 2026-08-05 | 2026-08-05 | on EDGAR ↗ |
| 10-Q | 2026-08-05 | 2026-06-30 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-07-31 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-07-30 | — | on EDGAR ↗ |
| 4 | 2026-07-29 | 2026-07-28 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about SRPT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →